VERTEX PHARMACEUTICALS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$558.88
+3.50%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+10.3%
3 months
+18.7%
6 months
+31.8%
1 year
+33.1%
Year to date
+23.3%
52-week range
$409.47 – $558.88
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$141.65B
P/E
32.2
P/B
7
P/S
11.3
Revenue
$12.59B
Net income
$4.41B
Diluted EPS
17.17
Gross margin
86.00%
Net margin
35.00%
Return on equity
23.30%
Total debt
$1.98B
Cash
$6.14B
Free cash flow
$3.8B
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $3.33B | $1.1B | 85.30% | 33.00% | $1.01B |
| Mar 31, 2026 | $2.99B | $1.03B | 86.80% | 34.50% | $1.29B |
| Dec 31, 2025 | $3.19B | $1.19B | 85.40% | 37.30% | $348.6M |
| Sep 30, 2025 | $3.08B | $1.08B | 86.50% | 35.20% | $1.14B |
| Jun 30, 2025 | $2.96B | $1.03B | 86.30% | 34.80% | $927.4M |
| Mar 31, 2025 | $2.77B | $646.3M | 86.90% | 23.30% | $778.2M |
| Dec 31, 2024 | $2.91B | $913M | 85.50% | 31.40% | $492M |
| Sep 30, 2024 | $2.77B | $1.05B | 85.80% | 37.70% | $1.3B |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent VRTX news
All market newsNo ticker-linked stories are in the current archive.